Mind Medicine Australia exists to help alleviate the suffering and suicides caused by mental illness in Australia through expanding the treatment options available to medical practitioners and their patients. We will establish safe and effective psychedelic-assisted treatments to treat a range of mental illnesses.
Mind Medicine Australia is a registered charity founded by Tania de Jong AM and Peter Hunt AM. We are supporting clinical research and working towards regulatory-approved and evidence-based psychedelic-assisted therapies. We operate as a peak body that connects medical practitioners, consumers, academia, government, industry, regulatory bodies, philanthropists, investors and other stakeholders.
Mind Medicine Australia is focused specifically on the clinical application of medicinal psilocybin and medicinal MDMA for certain mental illnesses. Our focus is wholly clinical.
Indications of success
- These therapies become an integral part of our Mental Health System
- With high remission rates leading to a substantial improvement in our Mental Health Statistics
- And that these therapies are accessible and affordable to all Australians in need
Four key strategic areas
MMA is building the ecosystem for these treatments through educating a diverse range of stakeholders via information sessions, screenings and other special events; the formation of metropolitan, rural and regional Chapters; the production of a major International Summit on Psychedelic Therapies for Mental Illness and range of other events; delivery of the first accredited practitioner training course in the Southern Hemisphere and a Psychological Support Service and other professional development programs; development of the Asia-Pacific Centre in Emerging Mental Health Therapies; funding for relevant novel clinical trials; the development of an appropriate legal and ethical structure in discussion with regulators; the development of reliable sources of pharmaceutical grade medicines in Australia and the roll-out of clinics.
Mind Medicine Australia is committed to creating a diverse and inclusive environment and is proud to be an equal opportunity employer. All qualified applicants receive consideration for employment without regard to race, colour, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status. Mind Medicine Australia associated practitioners also offer an inclusive and safe place for patients to receive care. We respect and value the cultural differences between us.
We support and fund clinical psychedelic research, conducted by independent institutions and affiliates.
By developing relationships between government, academic institutions, interest groups and regulatory bodies, Mind Medicine Australia aims to facilitate evidence-based change.
Education & Events
We educate the general public, medical and mental health practitioners, regulators, and other stakeholders on clinical psychedelic research and therapeutic application.
Mind Medicine Australia will act as the interface between research and practice by translating clinical research into accredited therapist training protocols.